# Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage

> **NCT07724405** · PHASE2 · RECRUITING · sponsor: **Fakih IVF Fertility Center** · enrollment: 150 (estimated)

## Conditions studied

- Recurrent Pregnancy Loss
- Recurrent Miscarriages

## Interventions

- **DRUG:** Placebo control
- **DRUG:** Recombinant G-CSF

## Key facts

- **NCT ID:** NCT07724405
- **Lead sponsor:** Fakih IVF Fertility Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2027-08-10
- **Final completion:** 2027-10-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07724405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07724405, "Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07724405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*